1. Home
  2. DRS vs LEGN Comparison

DRS vs LEGN Comparison

Compare DRS & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leonardo DRS Inc.

DRS

Leonardo DRS Inc.

HOLD

Current Price

$34.09

Market Cap

8.8B

Sector

Industrials

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$21.84

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRS
LEGN
Founded
1969
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
5.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DRS
LEGN
Price
$34.09
$21.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
13
Target Price
$46.83
$69.58
AVG Volume (30 Days)
816.3K
2.3M
Earning Date
10-29-2025
11-12-2025
Dividend Yield
1.05%
N/A
EPS Growth
33.93
N/A
EPS
0.99
N/A
Revenue
$3,569,000,000.00
$909,045,000.00
Revenue This Year
$11.94
$68.52
Revenue Next Year
$6.66
$48.63
P/E Ratio
$34.65
N/A
Revenue Growth
12.27
74.75
52 Week Low
$28.17
$21.19
52 Week High
$49.31
$45.30

Technical Indicators

Market Signals
Indicator
DRS
LEGN
Relative Strength Index (RSI) 47.05 30.29
Support Level $32.43 $21.19
Resistance Level $34.89 $23.24
Average True Range (ATR) 0.78 0.82
MACD 0.23 0.17
Stochastic Oscillator 64.84 13.37

Price Performance

Historical Comparison
DRS
LEGN

About DRS Leonardo DRS Inc.

Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: